Updates are available Correction dated 2025-01-28
Click to view Correction: https://doi.org/10.1186/s12913-025-12302-x
-
Authors
Splinter, Marije J.
Ikram, M. Kamran
Helsper, Charles W.
Bindels, Patrick J.E.
de Schepper, Evelien I.T.
Licher, Silvan
-
Funding
Funding for this research was provided by:
ZonMw (05160482220001)
EU Joint Programme – Neurodegenerative Disease Research (10510062120001)
- License Information
-
More Information
Article History
Received: 29 December 2022
Accepted: 7 July 2023
First Online: 27 July 2023
Change Date: 28 January 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12913-025-12302-x
Declarations
:
: The authors declare no competing interests.
: The Rotterdam Study has been approved by the Medical Ethics Committee of the Erasmus MC (registration number MEC 02.1015) and by the Dutch Ministry of Health, Welfare, and Sport (Population Screening Act WBO, license number 1071272-159521-PG). The Rotterdam Study has been entered into the Netherlands National Trial Register (NTR; ) and into the WHO International Clinical Trials Registry Platform (ICTRP; ) under shared catalogue number NTR6831. All participants provided written informed consent to participate in the study and to have their information obtained from treating physicians. The current study was carried out in accordance with guidelines and regulations in the Declaration of Helsinki.
: Not applicable.
